Most Popular Brands: Zanaflex, Sirdalud Retard, Sirdalud
Tizanidine hydrochloride is a skeletal muscle relaxant used for treatment of muscle spasticity. Off label it is used for tension headaches, low back pain, and trigeminal neuralgia.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Stiffness/Spasticity | 406 |
|
|
|
|
44 | |
| Muscle spasms | 54 |
|
|
|
|
|
16 |
| Other | 37 |
|
|
3 | |||
| Muscle spasms, neck and shoulders | 31 |
|
|
|
|
5 | |
| Pain | 30 |
|
|
2 | |||
| Muscle Pain | 24 |
|
|
|
8 |
See all 671 patients currently taking Tizanidine HCl
Mouse over the table for more information
Top 10 dosages based on patients currently taking Tizanidine HCl. See all 45 dosages ►
| 0.25 2mg as needed | 0.5 2mg as needed | 10 2mg as needed | 1.5 2mg as needed | 16 mg all the time (24/7) | 1mg as needed | 2 2mg as needed | 2 4mg as needed | 2 mg all the time (24/7) | 2 mg as needed | 2mg as needed | 3 4mg as needed | 4 4mg as needed | 4 mg all the time (24/7) | 4 mg as needed | 4mg as needed | 6mg as needed | 8 mg as needed | as needed | daily | 4 mg weekly | 1 mcg daily | 1 mg daily | 2 mg daily | 3 mg daily | 4 mg daily | 4 mg one time | 5 mg daily | 6 mg daily | 8 mg daily | 10 mg daily | 12 mg daily | 14 mg daily | 16 mg daily | 18 mg daily | 20 mg daily | 24 mg daily | 28 mg daily | 30 mg daily | 32 mg daily | 36 mg daily | 40 mg daily | 100 mg daily | 300 mg daily | 600 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
5
|
3
|
1
|
14
|
4
|
2
|
4
|
6
|
31
|
1
|
1
|
6
|
37
|
1
|
1
|
3
|
68
|
1
|
163
|
1
|
5
|
35
|
100
|
9
|
69
|
3
|
35
|
11
|
19
|
23
|
1
|
4
|
6
|
1
|
1
|
2
|
2
|
1
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
45 | 38% |
|
|
Doctor's advice
|
24 | 21% |
|
|
Other
|
24 | 21% |
|
|
Side effects too severe
|
22 | 19% |
|
|
Personal research
|
9 | 8% |
|
|
Expense
|
7 | 6% |
|
|
Course of treatment ended
|
3 | 3% |
|
|
Not indicated
|
2 | 2% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 21, 2009.